Whereas most cancers reactivate the reverse transcriptase telomerase (TERT)19,20, 10–15% of all cancers maintain their telomeres by the recombination-based “alternative lengthening of telomeres” (ALT) mechanism21. This evidence concerns the gene TERT and cancer.